Published in Neuron on August 21, 2014
High-Throughput, High-Resolution Mapping of Protein Localization in Mammalian Brain by In Vivo Genome Editing. Cell (2016) 1.53
Applications of CRISPR-Cas systems in neuroscience. Nat Rev Neurosci (2015) 1.18
CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases. Mol Neurodegener (2015) 0.94
Deciphering the pathogenic consequences of chromosomal aberrations in human genetic disease. Mol Cytogenet (2014) 0.87
Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling. Development (2015) 0.86
CrisprGE: a central hub of CRISPR/Cas-based genome editing. Database (Oxford) (2015) 0.84
Assembly of hair bundles, an amazing problem for cell biology. Mol Biol Cell (2015) 0.83
An E3-ligase-based method for ablating inhibitory synapses. Nat Methods (2016) 0.83
Sex steroid hormones matter for learning and memory: estrogenic regulation of hippocampal function in male and female rodents. Learn Mem (2015) 0.80
N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy. PLoS Genet (2016) 0.80
Strategies for precision modulation of gene expression by epigenome editing: an overview. Epigenetics Chromatin (2015) 0.79
CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases. Front Mol Neurosci (2016) 0.79
α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors. Proc Natl Acad Sci U S A (2016) 0.78
A Toolkit for Orthogonal and in vivo Optical Manipulation of Ionotropic Glutamate Receptors. Front Mol Neurosci (2016) 0.77
Surgical extraction of human dorsal root ganglia from organ donors and preparation of primary sensory neuron cultures. Nat Protoc (2016) 0.76
Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming. Sci Rep (2016) 0.75
Genome Engineering with TALE and CRISPR Systems in Neuroscience. Front Genet (2016) 0.75
The application of CRISPR technology to high content screening in primary neurons. Mol Cell Neurosci (2017) 0.75
Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity. Yale J Biol Med (2016) 0.75
Brain tumor modeling using the CRISPR/Cas9 system: state of the art and view to the future. Oncotarget (2016) 0.75
Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b. Mol Ther (2017) 0.75
Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders. J Mov Disord (2016) 0.75
Association of morphine-induced analgesic tolerance with changes in gene expression of GluN1 and MOR1 in rat spinal cord and midbrain. Iran J Basic Med Sci (2016) 0.75
Immunocytochemistry and fluorescence imaging efficiently identify individual neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures. BMC Neurosci (2017) 0.75
Use of CRISPR/Cas9 to model brain diseases. Prog Neuropsychopharmacol Biol Psychiatry (2017) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Multiplex genome engineering using CRISPR/Cas systems. Science (2013) 55.53
RNA interference. Nature (2002) 22.28
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 18.01
Genome engineering using the CRISPR-Cas9 system. Nat Protoc (2013) 15.98
Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 13.50
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell (2013) 13.43
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell (2013) 13.37
Altering the genome by homologous recombination. Science (1989) 12.73
Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A (1988) 10.90
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol (2013) 8.40
Subregion- and cell type-restricted gene knockout in mouse brain. Cell (1996) 8.02
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell (2013) 7.99
Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science (2000) 7.86
Cas9 as a versatile tool for engineering biology. Nat Methods (2013) 6.87
Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J Physiol (1983) 6.04
Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science (1992) 5.46
RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods (2013) 4.85
Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci U S A (2002) 4.77
Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins. Neuron (2006) 4.21
Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron (2009) 4.18
Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity. J Neurosci (2004) 3.30
Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA (2004) 3.16
Analysis of excitatory synaptic action in pyramidal cells using whole-cell recording from rat hippocampal slices. J Physiol (1990) 3.04
Retrograde modulation of presynaptic release probability through signaling mediated by PSD-95-neuroligin. Nat Neurosci (2007) 2.90
Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci (1990) 2.21
Characterization of genomic deletion efficiency mediated by clustered regularly interspaced palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells. J Biol Chem (2014) 2.18
Distinct modes of AMPA receptor suppression at developing synapses by GluN2A and GluN2B: single-cell NMDA receptor subunit deletion in vivo. Neuron (2011) 1.78
Molecular mechanisms controlling calcium entry through AMPA-type glutamate receptor channels. Neuron (1995) 1.76
Retraction of synapses and dendritic spines induced by off-target effects of RNA interference. J Neurosci (2006) 1.68
Regulation of spine morphology and spine density by NMDA receptor signaling in vivo. Proc Natl Acad Sci U S A (2007) 1.58
NMDA receptors inhibit synapse unsilencing during brain development. Proc Natl Acad Sci U S A (2008) 1.52
Endonucleases: new tools to edit the mouse genome. Biochim Biophys Acta (2014) 0.95
Conditional mutagenesis in mice: the Cre/loxP recombination system. Int J Exp Pathol (1996) 0.95